Stryker Corporation

Medical Devices

Prices are adjusted according to historical splits.

Stryker Corporation Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$105.64 billion
Book Value:
Revenue TTM:
$18.95 billion
Operating Margin TTM:
Gross Profit TTM:
$11.65 billion
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Stryker Corporation had its IPO on 1988-02-01 under the ticker symbol SYK.

The company operates in the Healthcare sector and Medical Devices industry. Stryker Corporation has a staff strength of 51,000 employees.

Stock update

Shares of Stryker Corporation opened at $278.92 at the start of the last trading session i.e. 2023-06-03.

The stocks traded within a range of $277.34 - $280.39, and closed at $278.3.

This is a -0.1% slip from the previous day's closing price.

A total volume of 1,411,100 shares were traded at the close of the day’s session.

In the last one week, shares of Stryker Corporation have increased by +2.11%.

Stryker Corporation's Key Ratios

Stryker Corporation has a market cap of $105.64 billion, indicating a price to book ratio of 5.8345 and a price to sales ratio of 5.3517.

In the last 12-months Stryker Corporation’s revenue was $18.95 billion with a gross profit of $11.65 billion and an EBITDA of $4.65 billion. The EBITDA ratio measures Stryker Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Stryker Corporation’s operating margin was 19.18% while its return on assets stood at 6.23% with a return of equity of 16.45%.

In Q1, Stryker Corporation’s quarterly earnings growth was a positive 83.3% while revenue growth was a positive 11.8%.

Stryker Corporation’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $6.88 per share while it has a forward price to earnings multiple of 25.5102 and a PEG multiple of 2.8533. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Stryker Corporation’s profitability.

Stryker Corporation stock is trading at a EV to sales ratio of 5.9792 and a EV to EBITDA ratio of 27.8885. Its price to sales ratio in the trailing 12-months stood at 5.3517.

Stryker Corporation stock pays annual dividends of $2.89 per share, indicating a yield of 1.08% and a payout ratio of 30.97%.

Balance sheet and cash flow metrics

Total Assets
$36.83 billion
Total Liabilities
$5.87 billion
Operating Cash Flow
Capital Expenditure
$130 million
Dividend Payout Ratio

Stryker Corporation ended 2023 with $36.83 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $36.83 billion while shareholder equity stood at $16.90 billion.

Stryker Corporation ended 2023 with $0 in deferred long-term liabilities, $5.87 billion in other current liabilities, 38000000.00 in common stock, $15.07 billion in retained earnings and $14.85 billion in goodwill. Its cash balance stood at $1.67 billion and cash and short-term investments were $1.76 billion. The company’s total short-term debt was $1,204,000,000 while long-term debt stood at $11.86 billion.

Stryker Corporation’s total current assets stands at $10.16 billion while long-term investments were $0 and short-term investments were $86.00 million. Its net receivables were $3.22 billion compared to accounts payable of $1.37 billion and inventory worth $4.33 billion.

In 2023, Stryker Corporation's operating cash flow was $-132000000.00 while its capital expenditure stood at $130 million.

Comparatively, Stryker Corporation paid $0.31 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Stryker Corporation stock is currently trading at $278.3 per share. It touched a 52-week high of $306.56 and a 52-week low of $306.56. Analysts tracking the stock have a 12-month average target price of $313.82.

Its 50-day moving average was $286.54 and 200-day moving average was $248.84 The short ratio stood at 2.34 indicating a short percent outstanding of 0%.

Around 647.5% of the company’s stock are held by insiders while 8008.5% are held by institutions.

Frequently Asked Questions About Stryker Corporation

The stock symbol (also called stock or share ticker) of Stryker Corporation is SYK

The IPO of Stryker Corporation took place on 1988-02-01

Similar Industry Stocks (Medical Devices)

Last Price
Kesko Oyj ADR (KKOYY)

Most Active

Last Price
Zomato Limited (ZOMATO)
Tesla Inc (TSLA)
Yes Bank Limited (YESBANK)

Top Gainers

Last Price
AEye Inc (LIDRW)

Top Losers

Last Price


Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.


2825 Airview Boulevard, Kalamazoo, MI, United States, 49002